Windlas Biotech Limited (NSE:WINDLAS)
813.10
-20.00 (-2.40%)
Jun 1, 2026, 3:30 PM IST
Windlas Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 18.14 | 4.24 | 52.88 | 36.86 | 5.7 |
Short-Term Investments | 2,684 | 154.81 | 256.39 | 217.68 | 1,106 |
Trading Asset Securities | - | 2,234 | 1,734 | 1,065 | 648.24 |
Cash & Short-Term Investments | 2,702 | 2,393 | 2,044 | 1,320 | 1,760 |
Cash Growth | 12.92% | 17.08% | 54.86% | -25.03% | 224.44% |
Accounts Receivable | 2,274 | 1,669 | 1,363 | 1,169 | 1,108 |
Other Receivables | - | 5.84 | 6.66 | 4.38 | 22.13 |
Receivables | 2,274 | 1,674 | 1,369 | 1,173 | 1,130 |
Inventory | 618.24 | 813.84 | 621.89 | 747.38 | 587.1 |
Prepaid Expenses | - | 10.54 | 9.84 | 8.71 | 9.54 |
Other Current Assets | 674.41 | 359.7 | 268.08 | 286.61 | 329.76 |
Total Current Assets | 6,269 | 5,251 | 4,313 | 3,535 | 3,817 |
Property, Plant & Equipment | 2,660 | 2,219 | 1,803 | 1,227 | 983.15 |
Long-Term Investments | - | 0.5 | 16.38 | 52.44 | 25.61 |
Other Intangible Assets | 69.11 | 67.79 | 44.68 | 14.84 | 8.82 |
Long-Term Deferred Tax Assets | 4.48 | 2.83 | 5.72 | 20.25 | 20.35 |
Other Long-Term Assets | 71.32 | 62.82 | 79.54 | 439.85 | 55.67 |
Total Assets | 9,073 | 7,605 | 6,262 | 5,290 | 4,910 |
Accounts Payable | 2,385 | 1,672 | 1,315 | 877.43 | 632.32 |
Accrued Expenses | 18.12 | 390.73 | 336.36 | 282.13 | 228.55 |
Short-Term Debt | - | - | - | - | 53.13 |
Current Portion of Long-Term Debt | 298.75 | 271.17 | 1.09 | 3.35 | 3.64 |
Current Portion of Leases | 32.19 | 32.29 | 15.14 | 15.32 | 5.16 |
Current Income Taxes Payable | 22.92 | - | - | 5.91 | - |
Other Current Liabilities | 452.39 | 127.87 | 49.81 | 28.28 | 17.06 |
Total Current Liabilities | 3,209 | 2,494 | 1,718 | 1,212 | 939.86 |
Long-Term Debt | - | - | - | 1.09 | 4.44 |
Long-Term Leases | 21.48 | 22.51 | 20.18 | 30.17 | - |
Other Long-Term Liabilities | 34.32 | 29.84 | 25.01 | 23.36 | 18.03 |
Total Liabilities | 3,265 | 2,547 | 1,763 | 1,267 | 962.33 |
Common Stock | 105.53 | 104.8 | 103.99 | 104.63 | 108.97 |
Additional Paid-In Capital | - | 1,989 | 1,946 | 1,986 | 2,269 |
Retained Earnings | - | 2,907 | 2,396 | 1,900 | 1,551 |
Comprehensive Income & Other | 5,703 | 56.99 | 53.45 | 32.19 | 18.04 |
Total Common Equity | 5,808 | 5,058 | 4,499 | 4,023 | 3,948 |
Shareholders' Equity | 5,808 | 5,058 | 4,499 | 4,023 | 3,948 |
Total Liabilities & Equity | 9,073 | 7,605 | 6,262 | 5,290 | 4,910 |
Total Debt | 352.42 | 325.97 | 36.41 | 49.93 | 66.37 |
Net Cash (Debt) | 2,349 | 2,067 | 2,007 | 1,270 | 1,694 |
Net Cash Growth | 13.68% | 2.97% | 58.08% | -25.04% | 673.25% |
Net Cash Per Share | 110.13 | 97.82 | 96.16 | 58.69 | 82.64 |
Filing Date Shares Outstanding | 21.11 | 20.96 | 20.8 | 20.95 | 21.79 |
Total Common Shares Outstanding | 21.11 | 20.96 | 20.8 | 20.95 | 21.79 |
Working Capital | 3,059 | 2,757 | 2,595 | 2,323 | 2,877 |
Book Value Per Share | 275.20 | 241.31 | 216.33 | 192.05 | 181.14 |
Tangible Book Value | 5,739 | 4,990 | 4,455 | 4,008 | 3,939 |
Tangible Book Value Per Share | 271.93 | 238.08 | 214.18 | 191.34 | 180.73 |
Land | - | 313.59 | 313.59 | 313.59 | 215.71 |
Buildings | - | 807.45 | 637.58 | 489.59 | 453.6 |
Machinery | - | 1,970 | 1,639 | 1,005 | 890.46 |
Construction In Progress | - | 32.01 | 57.08 | 138.01 | 75.81 |